Annual Non Current Assets
$13.60 B
+$270.60 M+2.03%
31 December 2023
Summary:
Regeneron Pharmaceuticals annual long term assets is currently $13.60 billion, with the most recent change of +$270.60 million (+2.03%) on 31 December 2023. During the last 3 years, it has risen by +$6.22 billion (+84.19%). REGN annual non current assets is now at all-time high.REGN Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$18.11 B
+$1.10 B+6.49%
30 September 2024
Summary:
Regeneron Pharmaceuticals quarterly long term assets is currently $18.11 billion, with the most recent change of +$1.10 billion (+6.49%) on 30 September 2024. Over the past year, it has increased by +$4.58 billion (+33.85%). REGN quarterly non current assets is now at all-time high.REGN Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
REGN Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.0% | +33.9% |
| 3 y3 years | +84.2% | +83.0% |
| 5 y5 years | +157.3% | +165.1% |
REGN Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +84.2% | at high | +83.0% |
| 5 y | 5 years | at high | +157.3% | at high | +175.7% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Regeneron Pharmaceuticals Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $18.11 B(+6.5%) |
| June 2024 | - | $17.01 B(+9.7%) |
| Mar 2024 | - | $15.50 B(+13.9%) |
| Dec 2023 | $19.48 B(+22.6%) | $13.60 B(+0.5%) |
| Sept 2023 | - | $13.53 B(-1.5%) |
| June 2023 | - | $13.73 B(+4.4%) |
| Mar 2023 | - | $13.15 B(-1.3%) |
| Dec 2022 | $15.88 B(+13.3%) | $13.33 B(+8.8%) |
| Sept 2022 | - | $12.25 B(+4.9%) |
| June 2022 | - | $11.68 B(-3.0%) |
| Mar 2022 | - | $12.04 B(+5.5%) |
| Dec 2021 | $14.01 B(+43.3%) | $11.42 B(+15.4%) |
| Sept 2021 | - | $9.90 B(+21.4%) |
| June 2021 | - | $8.15 B(+5.6%) |
| Mar 2021 | - | $7.72 B(+4.5%) |
| Dec 2020 | $9.78 B(+27.2%) | $7.38 B(+5.7%) |
| Sept 2020 | - | $6.99 B(+6.4%) |
| June 2020 | - | $6.57 B(-7.7%) |
| Mar 2020 | - | $7.11 B(-0.0%) |
| Dec 2019 | $7.69 B(+19.3%) | $7.12 B(+4.2%) |
| Sept 2019 | - | $6.83 B(+4.7%) |
| June 2019 | - | $6.52 B(+10.1%) |
| Mar 2019 | - | $5.93 B(+12.1%) |
| Dec 2018 | $6.45 B(+48.7%) | $5.29 B(+3.9%) |
| Sept 2018 | - | $5.09 B(-1.0%) |
| June 2018 | - | $5.14 B(+6.4%) |
| Mar 2018 | - | $4.83 B(+9.0%) |
| Dec 2017 | $4.33 B(+36.3%) | $4.43 B(-3.0%) |
| Sept 2017 | - | $4.57 B(+7.5%) |
| June 2017 | - | $4.25 B(+2.4%) |
| Mar 2017 | - | $4.15 B(+9.4%) |
| Dec 2016 | $3.18 B(+9.1%) | $3.79 B(+14.0%) |
| Sept 2016 | - | $3.33 B(+11.0%) |
| June 2016 | - | $3.00 B(+8.1%) |
| Mar 2016 | - | $2.77 B(+2.9%) |
| Dec 2015 | $2.92 B(+39.8%) | $2.69 B(+7.4%) |
| Sept 2015 | - | $2.51 B(+11.8%) |
| June 2015 | - | $2.24 B(+18.8%) |
| Mar 2015 | - | $1.89 B(+7.7%) |
| Dec 2014 | $2.08 B(+16.0%) | $1.75 B(+13.9%) |
| Sept 2014 | - | $1.54 B(+0.1%) |
| June 2014 | - | $1.54 B(+10.7%) |
| Mar 2014 | - | $1.39 B(+20.4%) |
| Dec 2013 | $1.80 B(+49.0%) | $1.15 B(+14.7%) |
| Sept 2013 | - | $1.01 B(+23.2%) |
| June 2013 | - | $816.90 M(-15.7%) |
| Mar 2013 | - | $968.88 M(+10.8%) |
| Dec 2012 | $1.21 B(+81.1%) | $874.48 M(+22.8%) |
| Sept 2012 | - | $712.01 M(+3.4%) |
| June 2012 | - | $688.31 M(+5.4%) |
| Mar 2012 | - | $653.24 M(-0.7%) |
| Dec 2011 | $665.78 M(+86.2%) | $657.81 M(+2.3%) |
| Sept 2011 | - | $643.16 M(+1.5%) |
| June 2011 | - | $633.59 M(-15.4%) |
| Mar 2011 | - | $748.79 M(+2.3%) |
| Dec 2010 | $357.62 M(-16.0%) | $731.81 M(+99.6%) |
| Sept 2010 | - | $366.71 M(-1.7%) |
| June 2010 | - | $372.89 M(-4.8%) |
| Mar 2010 | - | $391.71 M(+24.1%) |
| Dec 2009 | $425.51 M(-18.4%) | $315.69 M(+12.5%) |
| Sept 2009 | - | $280.60 M(+1.2%) |
| June 2009 | - | $277.31 M(+40.3%) |
| Mar 2009 | - | $197.63 M(-2.5%) |
| Dec 2008 | $521.44 M(-34.6%) | $202.78 M(+83.8%) |
| Sept 2008 | - | $110.35 M(+1.4%) |
| June 2008 | - | $108.83 M(-24.1%) |
| Mar 2008 | - | $143.37 M(+3.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | $797.83 M(+69.8%) | $138.43 M(-8.4%) |
| Sept 2007 | - | $151.08 M(+49.8%) |
| June 2007 | - | $100.88 M(-10.1%) |
| Mar 2007 | - | $112.27 M(-2.5%) |
| Dec 2006 | $469.98 M(+37.7%) | $115.11 M(+41.3%) |
| Sept 2006 | - | $81.44 M(-6.7%) |
| June 2006 | - | $87.28 M(+5.9%) |
| Mar 2006 | - | $82.44 M(+0.4%) |
| Dec 2005 | $341.39 M(-0.7%) | $82.11 M(-12.9%) |
| Sept 2005 | - | $94.32 M(+7.6%) |
| June 2005 | - | $87.64 M(-12.7%) |
| Mar 2005 | - | $100.44 M(-22.2%) |
| Dec 2004 | $343.95 M(+7.4%) | $129.15 M(-20.0%) |
| Sept 2004 | - | $161.45 M(+54.0%) |
| June 2004 | - | $104.84 M(-7.9%) |
| Mar 2004 | - | $113.89 M(-28.5%) |
| Dec 2003 | $320.21 M(+15.6%) | $159.35 M(+65.8%) |
| Sept 2003 | - | $96.12 M(-4.3%) |
| June 2003 | - | $100.40 M(-0.3%) |
| Mar 2003 | - | $100.70 M(-12.1%) |
| Dec 2002 | $276.95 M(-29.7%) | $114.63 M(+9.4%) |
| Sept 2002 | - | $104.77 M(-19.9%) |
| June 2002 | - | $130.75 M(-3.0%) |
| Mar 2002 | - | $134.75 M(+33.1%) |
| Dec 2001 | $394.19 M(+193.9%) | $101.21 M(+53.6%) |
| Sept 2001 | - | $65.89 M(-21.1%) |
| June 2001 | - | $83.51 M(+33.5%) |
| Mar 2001 | - | $62.55 M(-15.6%) |
| Dec 2000 | $134.14 M(+83.8%) | $74.13 M(-6.5%) |
| Sept 2000 | - | $79.32 M(+22.7%) |
| June 2000 | - | $64.65 M(+10.4%) |
| Mar 2000 | - | $58.55 M(-8.5%) |
| Dec 1999 | $73.00 M(-21.4%) | $64.00 M(+6.3%) |
| Sept 1999 | - | $60.20 M(-5.3%) |
| June 1999 | - | $63.60 M(-13.0%) |
| Mar 1999 | - | $73.10 M(+14.2%) |
| Dec 1998 | $92.90 M(-6.7%) | $64.00 M(-12.6%) |
| Sept 1998 | - | $73.20 M(-4.6%) |
| June 1998 | - | $76.70 M(+8.8%) |
| Mar 1998 | - | $70.50 M(+2.5%) |
| Dec 1997 | $99.60 M(+17.2%) | $68.80 M(+9.9%) |
| Sept 1997 | - | $62.60 M(+5.4%) |
| June 1997 | - | $59.40 M(+3.8%) |
| Mar 1997 | - | $57.20 M(+8.7%) |
| Dec 1996 | $85.00 M(+72.8%) | $52.60 M(-8.0%) |
| Sept 1996 | - | $57.20 M(-0.7%) |
| June 1996 | - | $57.60 M(+20.8%) |
| Mar 1996 | - | $47.70 M(+7.0%) |
| Dec 1995 | $49.20 M(-5.4%) | $44.60 M(+2.3%) |
| Sept 1995 | - | $43.60 M(-0.7%) |
| June 1995 | - | $43.90 M(-8.9%) |
| Mar 1995 | - | $48.20 M(+14.2%) |
| Dec 1994 | $52.00 M(-43.4%) | $42.20 M(-16.3%) |
| Sept 1994 | - | $50.40 M(0.0%) |
| June 1994 | - | $50.40 M(-17.9%) |
| Mar 1994 | - | $61.40 M(+138.0%) |
| Dec 1993 | $91.80 M(+8.4%) | $25.80 M(+58.3%) |
| Sept 1993 | - | $16.30 M(+10.9%) |
| June 1993 | - | $14.70 M(+6.5%) |
| Mar 1993 | - | $13.80 M(+4.5%) |
| Dec 1992 | $84.70 M(-20.5%) | $13.20 M(+5.6%) |
| Sept 1992 | - | $12.50 M(+10.6%) |
| June 1992 | - | $11.30 M(+15.3%) |
| Mar 1992 | - | $9.80 M(+32.4%) |
| Dec 1991 | $106.60 M(+375.9%) | $7.40 M(+68.2%) |
| Sept 1991 | - | $4.40 M(+12.8%) |
| June 1991 | - | $3.90 M(+30.0%) |
| Dec 1990 | $22.40 M | $3.00 M |
FAQ
- What is Regeneron Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual non current assets year-on-year change?
- What is Regeneron Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly non current assets year-on-year change?
What is Regeneron Pharmaceuticals annual long term assets?
The current annual non current assets of REGN is $13.60 B
What is the all time high annual non current assets for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual long term assets is $13.60 B
What is Regeneron Pharmaceuticals annual non current assets year-on-year change?
Over the past year, REGN annual long term assets has changed by +$270.60 M (+2.03%)
What is Regeneron Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of REGN is $18.11 B
What is the all time high quarterly non current assets for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly long term assets is $18.11 B
What is Regeneron Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, REGN quarterly long term assets has changed by +$4.58 B (+33.85%)